Press release
Polymyalgia Rheumatica Treatment Market Grows at 4.7% CAGR to 2035
The Polymyalgia Rheumatica (PMR) Treatment Market is a specialized segment within the global pharmaceutical and healthcare industry focused on managing polymyalgia rheumatica-a chronic inflammatory disorder that primarily affects adults over 50 years of age. PMR is characterized by muscle pain, stiffness, and inflammation, especially around the shoulders, neck, and hips. Effective treatment is critical to improving quality of life and preventing complications such as giant cell arteritis.
In 2025, the global PMR treatment market was valued at USD 213.31 million, driven by rising awareness of the disease, increased prevalence among the aging population, and advances in therapeutic options. The market is projected to grow at a CAGR of 4.70% from 2026 to 2035, potentially reaching USD 337.66 million by 2035. This growth reflects the expanding patient base, increasing diagnosis rates, and broader adoption of corticosteroids and other treatment classes.
Get a Free Sample Report with Table of Contents - https://www.expertmarketresearch.com/reports/polymyalgia-rheumatica-treatment-market/requestsample.
How Big is the Polymyalgia Rheumatica Treatment Market and What Factors Are Driving Growth?
The PMR treatment market is expanding gradually due to increasing disease prevalence, awareness campaigns, and improvements in diagnostics and therapeutics. Healthcare providers are prioritizing early detection and proper treatment to prevent complications and improve patient outcomes.
Key Growth Drivers:
Rising incidence of PMR among the aging population globally
Advancements in diagnostic methods, including blood tests and imaging
Increasing awareness among clinicians and patients about early diagnosis and treatment
Availability and adoption of corticosteroids and DMARDs for symptom management
Growth in healthcare infrastructure and specialized clinics for rheumatology
Expansion of homecare services for long-term disease management
These factors collectively contribute to the market's steady growth trajectory, enhancing accessibility to treatment and improving overall patient outcomes.
Diagnostic Methods for Polymyalgia Rheumatica
Early and accurate diagnosis is crucial for effective PMR management. The primary diagnostic methods include:
Blood Tests: Measuring inflammatory markers such as ESR (erythrocyte sedimentation rate) and CRP (C-reactive protein)
Imaging Tests: Ultrasound and MRI to detect inflammation in muscles and joints
Accurate diagnosis ensures timely treatment, reducing pain, stiffness, and the risk of complications such as giant cell arteritis, which can lead to vision loss if untreated.
Market Breakup by Drug Class
The PMR treatment market is segmented based on the type of medication prescribed:
Corticosteroids: First-line therapy to reduce inflammation and relieve pain
Disease-Modifying Anti-Rheumatic Drugs (DMARDs): Used for patients who cannot tolerate corticosteroids or require long-term treatment
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Supportive therapy for pain and stiffness management
Others: Include immunosuppressants and emerging targeted therapies
Corticosteroids dominate the market due to their efficacy, though long-term use requires careful monitoring due to potential side effects such as osteoporosis, diabetes, and hypertension.
Market Breakup by Route of Administration
PMR medications are administered through various routes depending on patient needs and drug type:
Oral: Tablets or capsules, convenient for long-term treatment
Parenteral: Injectable forms, used in hospital settings or for patients with severe symptoms
This segmentation helps healthcare providers optimize treatment plans according to disease severity and patient preferences.
Read the Full Report with the Table of Contents - https://www.expertmarketresearch.com/reports/polymyalgia-rheumatica-treatment-market.
Market Breakup by End Use
PMR treatment is provided across multiple healthcare settings:
Hospitals: Major treatment providers for newly diagnosed or severe cases
Homecare: Increasing adoption for elderly patients and long-term management
Specialty Clinics: Focused care for rheumatology patients with tailored therapy
Others: Community health centers and outpatient care facilities
The growing homecare segment reflects the market's shift toward patient-centric care and the need for accessible treatment options.
Market Breakup by Region
North America
Largest market due to advanced healthcare infrastructure and high disease awareness
Presence of leading pharmaceutical companies and specialized rheumatology centers
Europe
Strong adoption in Germany, UK, France, and Italy
Increasing public and private healthcare initiatives supporting chronic disease management
Asia Pacific
Fastest-growing region due to rising elderly population and improving healthcare access
Expansion of specialty clinics and diagnostic services
Latin America
Moderate growth, driven by increased healthcare awareness and gradual adoption of corticosteroids and DMARDs
Middle East & Africa
Emerging market with growing rheumatology clinics and awareness programs
Opportunities for pharmaceutical companies to expand treatment access
Competitive Landscape: Key Companies in PMR Treatment
Leading players in the Polymyalgia Rheumatica Treatment Market include:
Sanofi SA
Apotex Corporation
GlaxoSmithKline plc
AbbVie Inc.
Horizon Therapeutics plc
Others
Strategic approaches by market leaders:
Development of novel corticosteroid formulations and DMARDs
Expansion into emerging markets and regions with high unmet needs
Collaborations with hospitals and specialty clinics for treatment programs
Investment in patient education and adherence programs
Emerging Trends in the Polymyalgia Rheumatica Treatment Market
Development of low-dose corticosteroid regimens to reduce side effects
Increasing use of DMARDs and biologics in steroid-resistant cases
Integration of telemedicine for monitoring and follow-up care
Expansion of homecare solutions for long-term patient management
Focus on personalized treatment plans based on patient comorbidities and response to therapy
Future Outlook
The PMR treatment market is expected to witness steady growth through 2035, driven by:
Rising prevalence of polymyalgia rheumatica globally
Increasing awareness among healthcare providers and patients
Technological advancements in diagnostics and personalized medicine
Expansion of homecare and specialty rheumatology services
Key opportunities include:
Introduction of novel therapies to minimize steroid dependence
Expansion in emerging markets with growing elderly populations
Development of patient-centric digital tools for treatment adherence
Strategic partnerships between pharmaceutical companies and healthcare providers
Browse More Reports
United States Topical Pain Relief Market - https://bit.ly/43Fje4N.
Cough Syrup Market - https://bit.ly/4oRldLU.
Emergency Medical Services (EMS) Vehicle Market - https://bit.ly/3JwPrV9.
India Biosimilar Market - https://bit.ly/4oX4xT4.
Media Contact
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Polymyalgia Rheumatica Treatment Market Grows at 4.7% CAGR to 2035 here
News-ID: 4318870 • Views: …
More Releases from Expert Market Research
Scar Treatment Market Grows at 11% CAGR to 2035
Scar Treatment Market: Global Trends, Growth Drivers, and Future Outlook
The Scar Treatment Market has witnessed remarkable growth in recent years, fueled by rising demand for cosmetic procedures, growing awareness of skin health, and innovations in scar management therapies. Scars, resulting from surgery, trauma, burns, or skin conditions, can cause both physical and psychological challenges. This has increased the focus on effective scar treatments, ranging from topical applications to advanced laser…
Smart Inhalers Market to Reach USD 108.30B by 2035
Smart Inhalers Market: Global Growth, Trends, and Future Outlook
The Smart Inhalers Market is revolutionizing the management of chronic respiratory diseases (CRDs) such as asthma and chronic obstructive pulmonary disease (COPD). With chronic respiratory illnesses affecting millions globally, adherence to inhaler therapy and proper medication usage remain critical challenges. Smart inhalers-equipped with sensors, Bluetooth connectivity, and mobile apps-provide real-time monitoring, reminders, and adherence data, enabling patients and healthcare providers to optimize…
CRISPR Technology Market Growing at 23.1% CAGR
CRISPR Technology Market: Global Growth Analysis, Trends, and Future Outlook
The CRISPR Technology Market has emerged as one of the most disruptive and high-growth segments in modern biotechnology. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has revolutionized gene editing by enabling scientists to precisely, efficiently, and cost-effectively modify DNA. What once took years of complex genetic engineering can now be achieved in weeks, accelerating innovation across healthcare, agriculture, industrial biotechnology,…
Radiotheranostics Market to Reach USD 34.27B by 2035
Radiotheranostics Market: Global Growth, Precision Oncology Trends, and Future Outlook
The Radiotheranostics Market is emerging as one of the most transformative segments within nuclear medicine and precision oncology. Radiotheranostics-also referred to as theranostics-combine diagnostic imaging and targeted radionuclide therapy using the same molecular target. This integrated approach allows clinicians to visualize disease, select the right patients, personalize treatment, and monitor therapeutic response with unprecedented accuracy.
The growing global cancer burden, limitations of…
More Releases for PMR
Starch Derivatives Market Outlook by 2021 : PMR
Starch derivatives, also known as modified starch, are prepared by enzymatically, physically or chemically treating native starch to alter its properties. Starch derivatives are used in a number of industries for various functions. They are used as thickeners and stabilizers in the food and beverage industry, as a tablet binder in the pharmaceutical industry, as an emulsifier in cosmetics, and fiber additive in the animal feed. Some of the other…
Yeast Ingredients Market Outlook by 2021 : PMR
Yeasts are chemoorganotrophs, as they use organic compounds to source energy and do not require sunlight for growth or survival. Yeasts are usually unicellular; although some species may be multi-cellular. The size of yeast depends on the species. Yeasts usually measure 3 to 4 µm in diameter. However, certain yeasts reach up to 40 µm in diameter. Yeasts reproduce asexually through mitosis (a process, in which, the chromosomes in a…
Confectionery Market Outlook by 2021 : PMR
The confectionery market is one of the growing sectors globally . Usually, confections are low in nutrients and high in calorie. Sugar-free confections are gaining popularity in the recent years due to factors such as increasing obesity rate, increasing number of diabetic patients, increasing nutritional and health concerns, and changing lifestyle. The confectionery market can be primarily divided into two broad categories: sugar confectionery and bakers’ confectionery . Sugar confectionery…
Cereal Bars Market Outlook by 2021 : PMR
A cereal bar is made up of nuts, oats, sugar, dry fruits, flour, honey, wheat, corn, and puffed rice. Cereal bars have always been perceived as on-the-go breakfast snack items that are healthier alternatives of chocolate and other snacks. Cereal bars are high in fiber and protein and low in carbohydrates, vitamins, minerals, sodium, and antioxidants. They come in various flavors such as chocolate, peanut butter, banana, caramel, banana, honey,…
Functional Flours Market Share by 2026 : PMR
The natural flours used for specialty applications in the food industry and undergoes different treatment process to improve their properties are called functional flours. The various properties of functional flours include cold binding capacity, thermal binding capacity, machinability, dough hydration etc. The functional flours are classified as waxy, multi-benefit, instant and granulated type depending on its features. They undergo different physical and nutritional treatment to enhance its features. In dietary…
Global Ceilings Market Snapshot by 2020 : PMR
Ceiling is overhead interior portion within the room which covers the upper portion of the room. Main purpose of ceiling is to achieve the desired height of the roof in the room. Ceilings are frequently decorated with attractive paintings, mosaic tiles and other different designs. Major advantage of decorated ceiling is that it gets protected from damage by fingers and dust. There are certain ceilings which are fire resistance; dropping…
